Stock Review by Chief Analyst: Idera Pharmaceuticals, Tranzbyte, Creative Edge Nutrition, and Elray Resources
14 Janeiro 2014 - 10:00AM
InvestorsHub NewsWire
Idera
Pharmaceuticals, Inc. (NASDAQ: IDRA) engages in the discovery
and development of novel synthetic DNA- and RNA- based drug
candidates. It is developing drug candidates designed to modulate
immune responses mediated through Toll-like Receptors (TLRs); and
evaluating gene silencing oligonucleotides (GSOs), which inhibit
the production of disease-associated proteins by targeting RNA. The
company is strengthening its senior management with seasoned
industry veterans. Read about them and get a company report at this
link: http://bit.ly/AnalystReviewIDRA copy and paste
to browser may be required
Tranzbyte, Inc.
(OTC: ERBB) is the driving force behind OneBode International,
Altitude Organix, and the YO!21 Debit Card. The company has been
actively pursuing new opportunities through a series of
acquisitions. Read about the company’s new endeavors and get a full
report at the link: http://bit.ly/AnalystReviewERBB copy
and paste to browser may be required
Creative Edge
Nutrition, Inc. (OTC: FITX) develops, markets, and sells
nutraceuticals and health supplements. It offers a range of
capsules, tablets, and powders, as well as science based products
in weight management, specific nutrition challenges, energy, and
fitness categories. The company, through its subsidiary, CEN
Biotech engages in the distribution of medical marijuana. An
agreement with Endexx Corp. will track the distribution of CEN
Biotech’s marijuana. Get the distribution agreement details at the
link: http://bit.ly/AnalystReviewFITX copy and paste
to browser may be required
Elray
Resources, Inc. (OTCQB: ELRA) operates as an online gaming
company. Splitrock owns and operates SierraCasino.com,
Knutspoker.com, and LuckyLucyBingo.com. The company has several
current projects. Read about them and get a full report at the
link: http://bit.ly/AnalystReviewELRA copy and paste
to browser may be required
Get our stock alerts ahead of
the crowd on your mobile device text keyword “Street” to
25827
EDITOR NOTES:
1. Information in this release is
fact checked and produced on a best efforts basis and reviewed by
Marc Bonacci, Chief Financial Analyst. However, we are only human
and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
2. This information is submitted as a
net-positive to companies mentioned, to increase awareness for
mentioned companies to our subscriber base and the investing
public.
3. If you wish to have your company
covered in more detail by our team, or wish to learn more about our
services, please contact us at editor@smallcapstreet.com.
4. For any urgent concerns or
inquiries, please contact us at compliance@smallcapstreet.com.
5. Are you a public company? Would
you like to see similar coverage on your company? Send us a full
investors' package to research@smallcapstreet.com for
consideration.
COMPLIANCE PROCEDURE
Content is researched, written and
reviewed on a best-effort basis. This document, article or report
is prepared by Small Cap Specialists, LLC and authored by Marc
Bonacci, Chief Financial Analyst. An outsourced research services
provider represented by Marc Bonacci, Chief Financial Analyst, has
only reviewed the information provided by Small Cap Specialists,
LLC in this article or report. Small Cap Specialists, LLC is not
entitled to veto, interfere or alter the articles, documents or
report once reviewed by the outsourced research provider
represented by Marc Bonacci, Chief Financial Analyst.
NOT FINANCIAL ADVICE
Small Cap Specialists, LLC makes no
warranty, expressed or implied, as to the accuracy or completeness
or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to
be construed as personal financial advice. Readers are encouraged
to consult their personal financial advisor before making any
decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Small Cap Specialists, LLC is not
responsible for any error which may be occasioned at the time of
printing of this document or any error, mistake or shortcoming. No
liability is accepted by Small Cap Specialists, LLC whatsoever for
any direct, indirect or consequential loss arising from the use of
this document. Small Cap Specialists, LLC expressly disclaims any
fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Small Cap Specialists, LLC does not
(1) guarantee the accuracy, timeliness, completeness or correct
sequencing of the information, or (2) warrant any results from use
of the information. The included information is subject to change
without notice.
SOURCE: SmallCapStreet.com
Creative Edge Nutrition (CE) (USOTC:FITX)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Creative Edge Nutrition (CE) (USOTC:FITX)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
